Gland Pharma Ltd receives GMP compliance from Danish Medicines Agency

The Pashamylaram Facility of Gland Pharma Limited has received certificate of Good Manufacturing Practices (GMP) Compliance from Danish Medicines Agency in connection with Marketing authorizations listing manufacturers located outside of the European Economic Area, for aseptically prepared Powder for injection, infusion and inhalation.

Shares of Gland Pharma Limited was last trading in BSE at Rs. 1859.05 as compared to the previous close of Rs. 1842.60. The total number of shares traded during the day was 3245 in over 390 trades.

The stock hit an intraday high of Rs. 1881.00 and intraday low of 1845.00. The net turnover during the day was Rs. 6043604.00.

Source : Equity Bulls

Keywords

GlandPharma INE068V01023 Pharmaceuticals GMPCompliance DanishMedicinesAgency